Bank Julius Baer & Co. A.G., Guernsey Branch Share Price

Certificat

SBISJB

CH1213250280

Real-time Bid/Ask 02:07:53 26/06/2024 pm IST
123.5 CHF / 124.1 CHF +1.64% Intraday chart for Bank Julius Baer & Co. A.G., Guernsey Branch
Current month+5.00%
1 month+6.47%
Date Price Change
25/24/25 121.8 -0.08%
24/24/24 121.9 +2.87%
20/24/20 118.5 +0.34%
19/24/19 118.1 +1.11%
18/24/18 116.8 -0.76%

Delayed Quote Swiss Exchange

Last update June 25, 2024 at 08:50 pm IST

More quotes

Static data

Product typeSprint- and Outperformance-Certificates
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Bank Julius Bär
SBISJB
ISINCH1213250280
Date issued 07/02/2023
Strike 79.3 CHF
Maturity 07/08/2024 (43 Days)
Parity 1 : 1
Emission price 79.3 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 121.9 CHF
Lowest since issue 75.45 CHF
Spread 0.6 CHF
Spread %0.48%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107.2 USD
Average target price
110.3 USD
Spread / Average Target
+2.88%
Consensus
  1. Stock Market
  2. Certificates
  3. SBISJB Certificat